Come up with a name for your new list and we'll add to it:
Biogen IDEC raised a round of funding on , . Investors include
Asset Management Ventures.
IDEC Pharmaceuticals Corporation is engaged in the development of targeted immunotherapies for cancer and autoimmune diseases. The company's products act chiefly through immune system mechanisms, exer…